The Identification of Immunological Biomarkers in Kidney Cancers

The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Lopez-Beltran, Antonio, Henriques, Vanessa, Cimadamore, Alessia, Santoni, Matteo, Cheng, Liang, Gevaert, Thomas, Blanca, Ana, Massari, Francesco, Scarpelli, Marina, Montironi, Rodolfo
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6225533/
https://ncbi.nlm.nih.gov/pubmed/30450335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00456
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados